Las Vegas, NV -- (SBWIRE) -- 12/30/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more. EquityObserver.com issues a special report on the following stocks:QuickLogic Corporation(NASDAQ:QUIK),Chelsea Therapeutics International Ltd.(NASDAQ:CHTP),GSV Capital Corp(NASDAQ:GSVC),Peregrine Pharmaceuticals(NASDAQ:PPHM)
QuickLogic Corporation(NASDAQ:QUIK)managed to keep its gain at 4.99% on above-normal volume of 946,795.00shares. The stock settled at $3.86, after floating in a range of $3.58 - 4.05. Its latest price has reached market capitalization of $202.19M. Its 52-week range has been $2.01 - 4.17. QuickLogic Corporation develops and markets semiconductor solutions. It is a fabless semiconductor company that design.
How Should Investors Trade QUIK Now?Don’t Miss out a Special Trend Analysis
Chelsea Therapeutics International Ltd.(NASDAQ:CHTP)trading on a volume of 945,442.00 shares, lower than its standard daily volume. Shares have been closed at $4.35.Over the last twelve months, the stock has gained476.16% and faced a worst price of $0.73.Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases.
Is CHTP a Solid Investment at These Levels?Read This Report for Details
GSV Capital Corp(NASDAQ:GSVC)is down at $12.24 on above- normal volume of 938,476.00 shares during the last trading day. The stock has its 12-month range $7.42 - 16.90. Its Intraday range is $12.22 - 12.85.GSV Capital Corp. (GSV Capital), formerly NeXt Innovation Corp., is a development-stage company.
How Should Investors Trade GSVC Now?Don’t Miss out a Special Trend Analysis
In the last trading day, Peregrine Pharmaceuticals(NASDAQ:PPHM)is on low volume, trading at a volume of versus its average daily volume ratio 986,637.00/1.09M shares. At $1.38, the stock has attained market capitalization of 221.25M.Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. The Company's pipeline of investigational monoclonal antibodies is based on two technology platforms.
Will Investors Buy PPHM After Reading This News?Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)